Cargando…
Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment
BACKGROUND: Gliomas are one of the most common types of primary brain tumors. It is usually evaluated by gadolinium(III)-based contrast agents by magnetic resonance imaging (MRI) in the clinic. Methotrexate (MTX), as a type of folate analog that inhibits the enzyme dihydrofolate reductase, is widely...
Autores principales: | Xu, Dan, Lu, Shu-Ting, Li, Yu-Shuang, Baidya, Aju, Mei, Hao, He, Yong, Wu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181113/ https://www.ncbi.nlm.nih.gov/pubmed/30323562 http://dx.doi.org/10.2147/DDDT.S178569 |
Ejemplares similares
-
Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI
por: T., Mortezazadeh, et al.
Publicado: (2020) -
Multifunctional nanoparticle PEG-Ce6-Gd for MRI-guided photodynamic therapy
por: Xu, Dan, et al.
Publicado: (2021) -
Nonsteroidal Anti-Inflammatory Drug Conjugated with Gadolinium (III) Complex as an Anti-Inflammatory MRI Agent
por: Sung, Bokyung, et al.
Publicado: (2023) -
TSPO Ligand-Methotrexate Prodrug Conjugates: Design, Synthesis, and Biological Evaluation
por: Laquintana, Valentino, et al.
Publicado: (2016) -
False Negativity of Tc-99m Labeled Sodium Phytate Bone Marrow Imaging Under the Effect of G-CSF Prescription in Aplastic Anemia: A Case Report
por: Kasenene, Akanganyira, et al.
Publicado: (2019)